EPT Fumarate
€ 76,00 – € 320,00Price range: € 76,00 through € 320,00
EPT Fumarate is described as a substituted tryptamine research material associated with N-ethyl-N-propyltryptamine, commonly abbreviated EPT.
The compound belongs to the N,N-dialkyltryptamine family and features an indole framework with ethyl and propyl substituents on the side-chain nitrogen.
The supplied source describes a crystalline powder preparation in fumarate salt form and identifies analytical research contexts involving chemical characterization, forensic identification, and comparative examination of tryptamine derivatives.
Its reported molecular formula and molecular weight require careful interpretation because the source provides a free-base molecular weight alongside a fumarate salt composition.
Claims concerning purity, independent laboratory testing, manufacturing consistency, and Certificates of Analysis have not been independently verified.
The material is not established as a certified reference material or validated quantitative calibrator.
For research use only. Not for human or veterinary use. Not for clinical, diagnostic, or consumptive applications.
EPT Fumarate – N-Ethyl-N-Propyltryptamine Research Material
Product Overview
EPT Fumarate is described in the supplied information as a substituted tryptamine research compound associated with N-ethyl-N-propyltryptamine.
The compound belongs to the N,N-dialkyltryptamine family and is structurally related to other substituted tryptamines.
Its proposed molecular framework contains an indole ring connected to an ethylamine side chain bearing ethyl and propyl substituents on the nitrogen atom.
The supplied material is described as a fine crystalline powder in fumarate salt form.
This chemical designation distinguishes the stated product from the corresponding EPT free base.
The source associates EPT with analytical chemistry, forensic compound identification, and comparative structural research involving tryptamine derivatives.
However, no actual batch-specific analytical report or independently verified salt-composition record accompanied the supplied information.
The stated chemical identity, purity, and physical characteristics therefore remain source-provided specifications.
The source also claims third-party testing, consistent manufacturing quality, and supporting analytical documentation.
These claims require verification against actual product-specific records.
No certified reference-material status, validated quantitative calibration performance, or pharmaceutical approval has been established.
Chemical Identity & Classification
The supplied source identifies EPT as N-ethyl-N-propyltryptamine, a substituted tryptamine belonging to the N,N-dialkyltryptamine family.
The reported chemical information includes:
- Common designation: EPT Fumarate
- Synonym: N-Ethyl-N-propyltryptamine fumarate
- Reported chemical name: N-Ethyl-N-[2-(1H-indol-3-yl)ethyl]propan-1-amine fumarate
- Chemical classification: Substituted tryptamine; N,N-dialkyltryptamine derivative
- Reported CAS Registry Number: 850032-68-7, identified by the source as the free-base CAS
- Reported free-base molecular formula: C15H22N2
- Reported free-base molecular weight: 230.35 g/mol
- Reported fumarate composition: C15H22N2 · C4H4O4
- Reported presentation: Fine crystalline powder
The supplied free-base molecular formula and molecular weight are approximately consistent.
However, the source identifies the product itself as a fumarate salt.
The fumarate preparation cannot automatically be assigned the molecular weight of the corresponding free base.
The stated fumarate composition represents a nominal combination of EPT and fumaric acid, but the source does not provide independent evidence establishing the actual salt stoichiometry.
Accordingly, the free-base molecular weight should not be presented as the verified molecular weight of the finished fumarate material.
The supplied CAS number is explicitly associated with the free base rather than independently verified as a salt-specific identifier.
Researchers may consult PubChem for public chemical-reference information, taking care to distinguish EPT free-base records from any corresponding fumarate salt information.
Chemical & Physical Characteristics
The supplied source describes EPT Fumarate as a fine crystalline powder.
No actual product-specific inspection report, particle-size measurement, melting-point determination, or quantitative solubility profile was provided.
The physical presentation therefore remains a source-provided description.
EPT is characterized by an indole-containing tryptamine framework and two different alkyl substituents attached to the side-chain nitrogen.
The ethyl and propyl groups distinguish its substitution pattern from related N,N-dialkyltryptamines.
The source identifies MET and DET as chemically related compounds suitable for structural comparison.
However, related chemical classification does not establish equivalent analytical behavior, stability, or toxicological characteristics.
The source does not provide experimentally verified melting-point data, solubility measurements, degradation profiles, or complete physicochemical characterization.
The fumarate designation is relevant because the chemical form of a substance may affect its reported formula, molecular weight, and other physicochemical properties.
The actual fumarate stoichiometry and hydration state, if any, were not independently established.
The source recommends cool, dry storage protected from light.
No validated product-specific stability study or established shelf-life specification accompanied this recommendation.
Purity & Analytical Verification
The supplied source claims ingredient purity of at least 98%, with independent laboratory verification.
However, no actual batch-specific Certificate of Analysis, chromatogram, mass spectrum, NMR spectrum, or independent laboratory report was provided.
Accordingly, the stated purity threshold is not independently confirmed.
The source identifies HPLC, LC-MS, and NMR spectroscopy as techniques associated with EPT characterization.
These analytical methods may provide information concerning chemical identity, structural characteristics, impurity profiles, and analytical specificity.
However, mentioning an analytical technique does not establish that it was performed on the actual product.
The distinction between free-base identity and fumarate salt composition is especially important when interpreting analytical documentation.
Verification of the EPT molecular structure does not independently establish the precise fumarate stoichiometry or the absence of other components.
The source describes EPT Fumarate as a reference material for analytical research.
That designation does not independently establish certified reference-material status or validated quantitative calibration performance.
No assigned measurement values, uncertainty statements, metrological traceability records, or independently verified salt-specific specifications were supplied.
Quality Control & Batch Integrity
The supplied source claims independent laboratory testing, batch-specific traceability, and ISO-compliant production.
It also states that a Certificate of Analysis may be available upon request.
No actual certificate, accreditation record, manufacturing audit, independent testing report, or batch-specific quality-control document accompanied these claims.
They therefore remain unverified supplier statements.
For reproducible scientific documentation, relevant records may include verified chemical identifiers, batch number, analytical findings, receipt date, and available storage history.
The distinction between the EPT free base and the claimed fumarate salt should be clearly documented.
The supplied information does not establish independently verified salt stoichiometry, ingredient purity, or batch consistency.
The claim of ISO-compliant production is insufficient to establish certification or accreditation.
No applicable standard number, certification body, scope, or supporting audit documentation was provided.
Where a material is described as suitable for reference-standard work, researchers should distinguish ordinary catalog material from a certified reference material.
Safety, Handling & Laboratory Precautions
EPT Fumarate is described as a synthetic tryptamine-related research compound with an incompletely established product-specific toxicological profile.
The supplied source refers to serotonergic receptor research, but it does not provide experimental findings sufficient to establish specific biological activity or exposure safety.
Laboratory personnel should consult applicable chemical-safety documentation and institutional procedures before receiving or examining the material.
Relevant precautions include restricted access, protective equipment, contamination prevention, accidental-exposure procedures, environmental controls, and appropriate chemical-waste management.
Structural similarity to other substituted tryptamines does not establish equivalent toxicological characteristics.
The material should remain secured against unauthorized access and separated from food, beverages, and non-research environments.
Because the actual salt composition, purity, and physical characteristics have not been independently confirmed, laboratory documentation should distinguish verified characteristics from supplier-provided statements.
Any accidental exposure or contamination incident should be managed according to institutional emergency procedures.
Packaging, Labeling & Storage
The supplied source describes protective packaging, appropriate chemical labeling, and professional shipment arrangements.
However, no actual packaging specification, container-validation report, or shipment-condition record was provided.
The source recommends cool, dry, light-protected storage and suggests a temperature range of 2–8°C for longer-term preservation.
No validated product-specific stability data was provided to establish that this temperature range is necessary or sufficient for a particular shelf life.
The source also refers to international shipping and regulatory compliance.
No shipment authorization, carrier documentation, or destination-specific legal determination was supplied to substantiate those statements.
Laboratory inventory records should preserve the product designation, claimed fumarate salt form, any available batch identifier, and relevant storage observations.
The reported free-base molecular weight should not be substituted for a verified fumarate salt molecular weight.
Storage and containment requirements should be determined through institutional risk assessment and available chemical-safety documentation.
Intended Research Use & Market Positioning
The supplied scientific context places EPT Fumarate within analytical research involving substituted tryptamines, N,N-dialkyltryptamine derivatives, and chemical identification.
Its proposed ethyl and propyl substitution pattern provides a basis for comparative examination of related molecular structures.
The source references chromatographic identification, mass-spectrometric characterization, and investigation of chemical stability.
These references describe laboratory research topics rather than evidence of validated performance for the actual material.
The supplied Raw Lab Chems catalog includes EPT Fumarate, corresponding to the listing discussed here.
For comparative chemical-catalog context, Raw Lab Chems also lists MET Fumarate and DPT Powder.
These are differently named tryptamine-related compounds and should not be treated as chemically identical or analytically interchangeable with EPT.
The supplied information does not establish equivalent chemical forms, ingredient purity, or analytical characteristics across these listings.
These references provide catalog context rather than evidence of certified reference-material status or product equivalence.
Ordering, Availability & Fulfillment
The supplied source describes protective packaging, shipment tracking, and international laboratory distribution.
No current inventory record, shipment authorization, carrier documentation, or verified delivery information was provided.
Consequently, no availability, delivery, customs-clearance, or transportation-compliance guarantee is asserted.
EPT and related substituted tryptamines may be subject to controlled-substance, analogue, pharmaceutical, or other chemical regulations depending on the jurisdiction.
Institutional acquisition, possession, transportation, importation, and exportation must be assessed under applicable laws.
Research-only labeling does not establish a legal exemption.
Legal & Regulatory Disclaimer
For research use only. Not for human or veterinary use. Not for clinical, diagnostic, or consumptive applications.
EPT Fumarate is described as a substituted tryptamine-related compound whose possession, acquisition, transfer, transportation, importation, exportation, and laboratory investigation may be restricted or prohibited depending on the jurisdiction.
The supplied information does not establish universal legal status or regulatory authorization.
Institutions remain responsible for determining the applicable legal requirements and obtaining any necessary permissions.
No medical approval, consumer-use authorization, or regulatory exemption is implied by this description.
| Quantity (0.5 grams) |
2 ,5 ,10 |
|---|
You must be logged in to post a review.

Reviews
There are no reviews yet.